Our results are corroborated by findings suggesting an association between treatment-induced SOX10 expression and a slow-cycling phenotype in both glioma and melanoma (Capparelli et al, 2022; Cronin et al, 2013; Lau et al, 2015; Sun et al, 2014). The gene discussed is SOX10; the disease is central nervous system cancer.